Elias I Ayoub, MD
Otolaryngology · Downey
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 52 years
- Creighton University School of Medicine, 1974
Offices
1 location
Looking this up.
Hospitals listed: Pih Health Downey Hospital · Uci Health-Lakewood. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ayoub’s office at (562) 862-5160 to ask if they take your plan before you enroll.
California Medical Board record
Licence G39256 · Current
Licensed to practise in California · since 1979 · expires 2027-05-31 · Creighton University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Pih Health Downey HospitalDowney, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of PIH Health, which runs 3 hospitalsPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
- Uci Health-LakewoodLakewood, CAAcute Care Hospital · Proprietary · Has an emergency departmentPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 1 of 5 · 48% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.105, Oct 2024 – Sep 2025
See every measure and the patient survey for Pih Health Downey Hospital
Behind the star rating — Deaths: 1 better, 5 the same, 0 worse of 6 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 2 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.28 (0.21 to 2.34) · 403 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.44 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.9 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 178 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.9 · 201 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.1 · 160 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 2,052 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,633 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,714 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.1 (0.61 to 5.59) · 276 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.19 (0.51 to 3.87) · 273 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.89 (0 to 18.8) · 29 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (0.84 to 9.46) · 25 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 63 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.29 (0 to 1.22) · 2,012 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.198 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 124 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23.1 · 614 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.7 · 229 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 16.5 · 234 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 495 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.3 to 16.8) · 432 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 156 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,108 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 39% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Uci Health-Lakewood
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.105 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.94 (0 to 1.97) · 512 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.15 (0.77 to 1.53) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.76 (139.14 to 246.38) · 35 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 57 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 56 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 149 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.2 · 264 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.5 · 223 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 1,866 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.07 to 0.51) · 3,098 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.07 to 0.48) · 3,262 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.72 (1.33 to 6.11) · 498 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.91 (1.29 to 4.53) · 492 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.25 (1.53 to 20.97) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 80 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.91 (0.24 to 1.58) · 2,875 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 89 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.584 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.28 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.498 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.265 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 181 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 403 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.3 · 56 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 32.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 89.6 · 289 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 495 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 96 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12 · 70 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.7 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.5 to 17.5) · 95 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.2) · 80 cases | No different | Jan 2024 – Dec 2024 |
What patients said (391 patients answered, 15% of those asked)
| Cleanliness | 3 |
| Nurse communication | 1 |
| Doctor communication | 1 |
| Communication about medicines | 1 |
| Discharge information | 2 |
| Overall hospital rating | 1 |
| Quietness | 1 |
| Recommend hospital | 1 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 66% |
| Doctors "always" communicated well | 68% |
| Staff "always" explained | 50% |
| Yes, staff "did" give patients this information | 79% |
| Yes, staff "did" give patients information about help after discharge | 78% |
| Doctors "always" explained things so they could understand | 62% |
| Doctors "always" listened carefully | 67% |
| Doctors "always" treated them with courtesy and respect | 75% |
| Patients who gave a rating of "9" or "10" (high) | 49% |
| Staff "always" explained new medications | 63% |
| Nurses "always" explained things so they could understand | 60% |
| Nurses "always" listened carefully | 64% |
| Nurses "always" treated them with courtesy and respect | 73% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 48% |
| Staff "always" explained possible side effects | 36% |
| Yes, staff "did" give patients information about possible symptoms | 80% |
Original Medicare doctor bills
$78,293
Medicare paid this office $78,293 for 433 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 293 | $36,127 | $64 |
| New patient visit (45+ min) | 184 | $19,957 | $108 |
| Removal of impacted ear wax | 217 | $10,627 | $34 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of impacted ear wax | – | – | 31 | 106 | 289 | 313 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
433 Original Medicare patients in 2024. Average age 74 · Under 65 12% · 85 and older 17% · Women 62% · Also on Medicaid 78% · Health risk score 1.72. Sicker patients than 9 in 10 peers; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 75% · Diabetes 56% · Coronary heart disease 28% · Chronic kidney disease 28% · Depression 23% · Heart failure 22% · COPD 20% · Dementia 13% · Atrial fibrillation 11% · Cancer 9% · Stroke 9%.
The office billed $172,910, Medicare allowed $113,377 and paid $78,293; for 1,165 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 433 | 1,165 | 74 | 1.72 | $172,910 | $78,293 |
| 2023 | 485 | 1,273 | 74 | 1.84 | $208,853 | $103,101 |
| 2022 | 459 | 1,068 | 74 | 1.86 | $195,765 | $97,806 |
| 2021 | 479 | 962 | 75 | 1.84 | $185,955 | $97,452 |
| 2020 | 433 | 901 | 73 | 2.00 | $206,655 | $91,525 |
| 2019 | 635 | 1,457 | 73 | 2.01 | $335,765 | $138,903 |
| 2018 | 656 | 1,463 | 74 | 2.33 | $313,680 | $129,475 |
| 2017 | 676 | 1,610 | 73 | 2.23 | $356,520 | $155,082 |
| 2016 | 841 | 2,048 | 73 | 2.10 | $432,090 | $194,414 |
| 2015 | 818 | 2,160 | 73 | 2.30 | $429,415 | $192,218 |
| 2014 | 855 | 2,412 | 74 | 2.13 | $475,290 | $211,779 |
| 2013 | 915 | 2,527 | 73 | 2.01 | $514,000 | $213,867 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Short return visit (20+ min) | 305 | $41,338 | $70 |
| New patient visit (45+ min) | 241 | $28,669 | $119 |
| Removal of impacted ear wax | 197 | $10,723 | $37 |
| Comprehensive hearing and speech recognition test | 13 | $386 | $30 |
| Test for eardrum and muscle function | 12 | $230 | $19 |
2022: 5 services
| Short return visit (20+ min) | 301 | $39,742 | $71 |
| New patient visit (45+ min) | 236 | $29,066 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $7,295 | $87 |
| Removal of impacted ear wax | 86 | $4,139 | $39 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,710 | $159 |
2021: 5 services
| Short return visit (20+ min) | 278 | $37,367 | $72 |
| New patient visit (45+ min) | 254 | $32,567 | $128 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $6,450 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,084 | $171 |
| Removal of impacted ear wax | 30 | $1,257 | $41 |
2020: 6 services
| Short return visit (20+ min) | 233 | $28,473 | $61 |
| New patient visit (45+ min) | 227 | $28,370 | $125 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $6,458 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,526 | $174 |
| Comprehensive hearing and speech recognition test | 13 | $287 | $22 |
| Test for eardrum and muscle function | 13 | $196 | $15 |
2019: 6 services
| New patient visit (45+ min) | 316 | $36,776 | $116 |
| Short return visit (20+ min) | 343 | $35,432 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $23,180 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $10,063 | $162 |
| Comprehensive hearing and speech recognition test | 20 | $572 | $29 |
| Test for eardrum and muscle function | 18 | $295 | $16 |
2018: 7 services
| New patient visit (45+ min) | 329 | $38,328 | $116 |
| Short return visit (20+ min) | 362 | $37,141 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $13,884 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 53 | $8,552 | $161 |
| Removal of impacted ear wax | 26 | $955 | $37 |
| Comprehensive hearing and speech recognition test | 31 | $891 | $29 |
| Test for eardrum and muscle function | 31 | $510 | $16 |
2017: 7 services
| Short return visit (20+ min) | 399 | $46,297 | $58 |
| New patient visit (45+ min) | 321 | $39,770 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $13,711 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $8,079 | $158 |
| Comprehensive hearing and speech recognition test | 61 | $1,861 | $31 |
| Test for eardrum and muscle function | 61 | $1,064 | $17 |
| New patient visit (30+ min) | 12 | $891 | $74 |
2016: 12 services
| New patient visit (45+ min) | 421 | $53,522 | $127 |
| Short return visit (20+ min) | 424 | $48,975 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 86 | $28,227 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 96 | $15,964 | $166 |
| Incision of windpipe for insertion of breathing tube (older than 2 years) | 15 | $5,136 | $342 |
| Long return visit (40+ min) | 25 | $2,774 | $111 |
| Comprehensive hearing and speech recognition test | 80 | $2,366 | $29 |
| Biopsy of voice box using an endoscope | 13 | $1,994 | $142 |
| New patient visit (30+ min) | 19 | $1,776 | $93 |
| Test for eardrum and muscle function | 80 | $1,317 | $16 |
| Return visit (30+ min) | 13 | $1,208 | $93 |
| Removal of impacted ear wax | 23 | $950 | $41 |
2015: 10 services
| New patient visit (45+ min) | 441 | $55,800 | $127 |
| Short return visit (20+ min) | 425 | $49,577 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 82 | $20,752 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 108 | $18,683 | $171 |
| Incision of windpipe for insertion of breathing tube (older than 2 years) | 19 | $6,494 | $342 |
| Comprehensive hearing and speech recognition test | 151 | $4,577 | $30 |
| Removal of impacted ear wax | 66 | $2,813 | $41 |
| Long return visit (40+ min) | 23 | $2,666 | $116 |
| Test for eardrum and muscle function | 151 | $2,581 | $17 |
| Biopsy of voice box using an endoscope | 12 | $1,664 | $139 |
2014: 11 services
| Short return visit (20+ min) | 488 | $55,751 | $57 |
| New patient visit (45+ min) | 376 | $49,324 | $131 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 87 | $24,700 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 94 | $15,946 | $168 |
| New patient visit (30+ min) | 70 | $5,300 | $76 |
| Incision of windpipe for insertion of breathing tube (older than 2 years) | 13 | $4,686 | $335 |
| Removal of impacted ear wax | 101 | $4,505 | $41 |
| Comprehensive hearing and speech recognition test | 144 | $4,397 | $30 |
| Long return visit (40+ min) | 27 | $3,150 | $117 |
| Test for eardrum and muscle function | 143 | $2,482 | $17 |
| Exam of the nose and throat using an endoscope | 11 | $1,356 | $123 |
2013: 11 services
| Short return visit (20+ min) | 527 | $60,047 | $57 |
| New patient visit (45+ min) | 254 | $33,099 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 91 | $27,585 | $84 |
| New patient visit (30+ min) | 230 | $18,983 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 102 | $16,773 | $163 |
| Incision of windpipe for insertion of breathing tube (older than 2 years) | 29 | $9,412 | $325 |
| Comprehensive hearing and speech recognition test | 147 | $4,108 | $28 |
| Removal of impacted ear wax | 76 | $3,831 | $45 |
| Test for eardrum and muscle function | 152 | $2,391 | $16 |
| Biopsy of voice box using an endoscope | 12 | $1,840 | $142 |
| Exam of the nose and throat using an endoscope | 13 | $1,662 | $128 |
Medicaid work
$137,346 in 2024
Medicaid paid $137,346 for 1,806 billed services this clinician did in 2024, up to 85 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 1,014 | $72,691 |
| New patient visit (45+ min) | 398 | $39,361 |
| New patient visit (30+ min) | 201 | $19,786 |
| Removal of impacted ear wax | 193 | $5,509 |
| 2024 | 1,806 | 4 | 85 | $137,346 |
| 2023 | 2,435 | 4 | 100 | $187,171 |
| 2022 | 1,946 | 4 | 98 | $170,537 |
| 2021 | 1,781 | 4 | 102 | $130,322 |
| 2020 | 1,446 | 3 | 90 | $73,087 |
| 2019 | 1,310 | 4 | 77 | $46,058 |
| 2018 | 921 | 2 | 63 | $24,663 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 1,354 | $96,854 |
| New patient visit (30+ min) | 392 | $41,288 |
| New patient visit (45+ min) | 425 | $41,231 |
| Removal of impacted ear wax | 264 | $7,798 |
2022
| Short return visit (20+ min) | 1,130 | $87,575 |
| New patient visit (30+ min) | 399 | $43,350 |
| New patient visit (45+ min) | 354 | $37,411 |
| Removal of impacted ear wax | 63 | $2,201 |
2021
| Short return visit (20+ min) | 978 | $55,736 |
| New patient visit (30+ min) | 482 | $38,069 |
| New patient visit (45+ min) | 307 | $35,928 |
| Removal of impacted ear wax | 14 | $589 |
2020
| New patient visit (30+ min) | 669 | $41,178 |
| Short return visit (20+ min) | 709 | $25,215 |
| New patient visit (45+ min) | 68 | $6,693 |
2019
| New patient visit (30+ min) | 575 | $25,028 |
| Short return visit (20+ min) | 710 | $19,755 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $846 |
| New patient visit (45+ min) | 13 | $429 |
2018
| Short return visit (20+ min) | 596 | $12,813 |
| New patient visit (30+ min) | 325 | $11,850 |
Drugs they prescribed that Part D paid
$155,442
Pharmacies billed $155,442 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,830 generic and 169 brand-name prescriptions · $155,442 in drug cost · 282 antibiotic prescriptions to 192 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 11 | $40,087 | $3,644 |
| Xhance | 35 | $33,101 | $946 |
| Ofloxacin | 123 | $12,973 | $105 |
| Ipratropium | 284 | $8,707 | $31 |
| Neomycin-Polymyxin-Hydrocort | 207 | $7,567 | $37 |
See all 28 drugs
| Dupixent | 11 | $40,087 | $3,644 |
| Xhance | 35 | $33,101 | $946 |
| Ofloxacin | 123 | $12,973 | $105 |
| Ipratropium | 284 | $8,707 | $31 |
| Neomycin-Polymyxin-Hydrocort | 207 | $7,567 | $37 |
| Fluticasone Propionate | 602 | $6,954 | $12 |
| Neomycin-Polymyxin-Hc | 105 | $4,236 | $40 |
| Pilocarpine | 58 | $4,095 | $71 |
| Montelukast | 312 | $2,912 | $9 |
| Azelastine | 86 | $2,688 | $31 |
| Dexlansoprazole Dr | 13 | $2,175 | $167 |
| Omeprazole | 185 | $1,774 | $10 |
| Ciprofloxacin-Dexamethasone | 23 | $1,499 | $65 |
| Mometasone Furoate | 36 | $1,229 | $34 |
| Ciprofloxacin | 49 | $1,213 | $25 |
| Fluocinolone Acetonide Oil | 27 | $983 | $36 |
| Triamcinolone Acetonide | 14 | $856 | $61 |
| Amoxicillin-Clavulanate Potass | 106 | $802 | $8 |
| Meclizine | 126 | $733 | $6 |
| Albuterol Sulfate Hfa | 30 | $726 | $24 |
| Pantoprazole | 48 | $671 | $14 |
| Methylprednisolone | 44 | $244 | $6 |
| Azithromycin | 83 | $195 | $2 |
| Naproxen | 67 | $180 | $3 |
| Cephalexin | 32 | $157 | $5 |
| Ondansetron | 13 | $113 | $9 |
| Levofloxacin | 21 | $93 | $4 |
| Ibuprofen | 13 | $31 | $2 |
Year by year
| 2024 | 3,016 | 924 | None | 6% | $155,442 |
| 2023 | 3,007 | 959 | 1% (21) | 3% | $126,153 |
| 2022 | 3,162 | 978 | 0% (11) | 4% | $133,395 |
| 2021 | 3,181 | 973 | 1% (26) | None | $137,135 |
| 2020 | 3,784 | 1,117 | 1% (32) | None | $158,863 |
| 2019 | 4,648 | 1,453 | 0% (13) | 9% | $230,503 |
| 2018 | 5,084 | 1,572 | 2% (80) | 7% | $253,129 |
| 2017 | 5,167 | 1,561 | 2% (99) | None | $232,192 |
| 2016 | 4,948 | 1,429 | 2% (112) | 10% | $228,573 |
| 2015 | 4,814 | 1,245 | 2% (93) | 12% | $221,931 |
| 2014 | 4,690 | 1,168 | 3% (133) | 13% | $192,732 |
| 2013 | 4,534 | 1,151 | 3% (138) | 16% | $210,308 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 28 drugs
| Neomycin-Polymyxin-Hydrocort | 244 | $13,836 | $57 |
| Fluticasone Propionate | 588 | $11,926 | $20 |
| Ofloxacin | 158 | $11,531 | $73 |
| Pilocarpine | 81 | $8,294 | $102 |
| Montelukast | 290 | $7,471 | $26 |
| Azelastine | 152 | $6,740 | $44 |
| Dexlansoprazole Dr | 21 | $6,690 | $319 |
| Ipratropium | 113 | $4,242 | $38 |
| Neomycin-Polymyxin-Hc | 59 | $3,224 | $55 |
| Ciprofloxacin-Dexamethasone | 26 | $3,005 | $116 |
| Omeprazole | 172 | $2,880 | $17 |
| Amoxicillin-Clavulanate Potass | 138 | $2,148 | $16 |
| Mometasone Furoate | 40 | $2,048 | $51 |
| Meclizine | 137 | $1,993 | $15 |
| Pantoprazole | 86 | $1,711 | $20 |
| Ciprofloxacin | 48 | $1,527 | $32 |
| Fluocinolone Acetonide Oil | 14 | $871 | $62 |
| Triamcinolone Acetonide | 25 | $657 | $26 |
| Cephalexin | 49 | $622 | $13 |
| Naproxen | 97 | $496 | $5 |
| Methylprednisolone | 49 | $494 | $10 |
| Azithromycin | 79 | $489 | $6 |
| Albuterol Sulfate Hfa | 13 | $481 | $37 |
| Clindamycin | 14 | $371 | $26 |
| Levofloxacin | 29 | $356 | $12 |
| Acetaminophen-Codeine | 18 | $176 | $10 |
| Ibuprofen | 28 | $113 | $4 |
| Amoxicillin | 12 | $62 | $5 |
2022: 27 drugs
| Neomycin-Polymyxin-Hydrocort | 268 | $17,267 | $64 |
| Ofloxacin | 116 | $11,858 | $102 |
| Fluticasone Propionate | 627 | $11,843 | $19 |
| Ciprofloxacin-Dexamethasone | 74 | $9,911 | $134 |
| Dexilant | 18 | $9,111 | $506 |
| Montelukast | 363 | $8,329 | $23 |
| Azelastine | 158 | $7,703 | $49 |
| Pilocarpine | 50 | $6,599 | $132 |
| Mometasone Furoate | 54 | $3,136 | $58 |
| Omeprazole | 213 | $2,716 | $13 |
| Amoxicillin-Clavulanate Potass | 143 | $2,135 | $15 |
| Neomycin-Polymyxin-Hc | 39 | $2,127 | $55 |
| Pantoprazole | 111 | $1,535 | $14 |
| Meclizine | 125 | $1,449 | $12 |
| Fluocinolone Acetonide Oil | 19 | $1,301 | $68 |
| Triamcinolone Acetonide | 15 | $934 | $62 |
| Methylprednisolone | 91 | $897 | $10 |
| Ciprofloxacin | 44 | $787 | $18 |
| Albuterol Sulfate Hfa | 17 | $695 | $41 |
| Naproxen | 126 | $620 | $5 |
| Cephalexin | 45 | $409 | $9 |
| Azithromycin | 64 | $367 | $6 |
| Levofloxacin | 53 | $357 | $7 |
| Ibuprofen | 35 | $178 | $5 |
| Insulin | 11 | $88 | $8 |
| Atorvastatin | 11 | $80 | $7 |
| Prednisone | 16 | $77 | $5 |
2021: 31 drugs
| Neomycin-Polymyxin-Hydrocort | 234 | $14,041 | $60 |
| Dexilant | 31 | $13,732 | $443 |
| Ofloxacin | 118 | $13,001 | $110 |
| Ciprofloxacin-Dexamethasone | 63 | $12,219 | $194 |
| Fluticasone Propionate | 533 | $9,956 | $19 |
| Montelukast | 536 | $8,905 | $17 |
| Pilocarpine | 50 | $6,737 | $135 |
| Azelastine | 116 | $6,283 | $54 |
| Mometasone Furoate | 52 | $3,665 | $70 |
| Amoxicillin-Clavulanate Potass | 156 | $2,994 | $19 |
| Omeprazole | 198 | $2,634 | $13 |
| Neomycin-Polymyxin-Hc | 31 | $1,990 | $64 |
| Triamcinolone Acetonide | 33 | $1,973 | $60 |
| Meclizine | 106 | $1,464 | $14 |
| Pantoprazole | 105 | $1,361 | $13 |
| Ciprofloxacin | 50 | $1,211 | $24 |
| Albuterol Sulfate Hfa | 17 | $754 | $44 |
| Methylprednisolone | 70 | $700 | $10 |
| Nystatin | 14 | $669 | $48 |
| Cephalexin | 64 | $607 | $9 |
| Azithromycin | 73 | $520 | $7 |
| Naproxen | 83 | $461 | $6 |
| Acetaminophen-Codeine | 25 | $281 | $11 |
| Famotidine | 11 | $262 | $24 |
| Atorvastatin | 22 | $253 | $12 |
| Levocetirizine Dihydrochloride | 15 | $250 | $17 |
| Ibuprofen | 51 | $244 | $5 |
| Levofloxacin | 25 | $202 | $8 |
| Mupirocin | 11 | $130 | $12 |
| Ondansetron | 12 | $112 | $9 |
| Prednisone | 16 | $102 | $6 |
2020: 33 drugs
| Ciprodex | 88 | $23,046 | $262 |
| Dexilant | 41 | $18,287 | $446 |
| Montelukast | 984 | $17,914 | $18 |
| Fluticasone Propionate | 690 | $13,326 | $19 |
| Neomycin-Polymyxin-Hydrocort | 215 | $13,281 | $62 |
| Ofloxacin | 121 | $8,118 | $67 |
| Azelastine | 147 | $7,804 | $53 |
| Mometasone Furoate | 52 | $5,052 | $97 |
| Ciprofloxacin-Dexamethasone | 19 | $3,889 | $205 |
| Neomycin-Polymyxin-Hc | 32 | $2,921 | $91 |
| Omeprazole | 230 | $2,875 | $12 |
| Pilocarpine | 29 | $2,599 | $90 |
| Pazeo | 11 | $2,271 | $206 |
| Triamcinolone Acetonide | 38 | $2,099 | $55 |
| Fluocinolone Acetonide Oil | 18 | $1,901 | $106 |
| Ciprofloxacin | 46 | $1,342 | $29 |
| Amoxicillin-Clavulanate Potass | 86 | $1,251 | $15 |
| Clotrimazole-Betamethasone | 12 | $1,096 | $91 |
| Meclizine | 116 | $1,062 | $9 |
| Pantoprazole | 70 | $777 | $11 |
| Albuterol Sulfate Hfa | 18 | $768 | $43 |
| Cephalexin | 62 | $602 | $10 |
| Methylprednisolone | 60 | $596 | $10 |
| Azithromycin | 85 | $570 | $7 |
| Levocetirizine Dihydrochloride | 20 | $520 | $26 |
| Levofloxacin | 43 | $437 | $10 |
| Acetaminophen-Codeine | 31 | $290 | $9 |
| Naproxen | 45 | $247 | $5 |
| Losartan | 21 | $224 | $11 |
| Ibuprofen | 45 | $187 | $4 |
| Amoxicillin | 17 | $145 | $9 |
| Glimepiride | 11 | $37 | $3 |
| Hydrochlorothiazide | 12 | $37 | $3 |
2019: 34 drugs
| Ciprodex | 244 | $57,875 | $237 |
| Dexilant | 62 | $31,822 | $513 |
| Montelukast | 1,325 | $30,250 | $23 |
| Fluticasone Propionate | 824 | $15,373 | $19 |
| Ofloxacin | 163 | $11,098 | $68 |
| Neomycin-Polymyxin-Hydrocort | 187 | $10,971 | $59 |
| Omeprazole | 330 | $8,050 | $24 |
| Azelastine | 157 | $7,689 | $49 |
| Mometasone Furoate | 65 | $6,516 | $100 |
| Pazeo | 23 | $4,494 | $195 |
| Esomeprazole Magnesium | 15 | $3,719 | $248 |
| Fluocinolone Acetonide Oil | 23 | $3,119 | $136 |
| Meclizine | 179 | $2,370 | $13 |
| Amoxicillin-Clavulanate Potass | 128 | $2,155 | $17 |
| Ciprofloxacin | 67 | $1,863 | $28 |
| Triamcinolone Acetonide | 19 | $1,674 | $88 |
| Methylprednisolone | 83 | $1,283 | $15 |
| Neomycin-Polymyxin-Hc | 21 | $990 | $47 |
| Cephalexin | 61 | $642 | $11 |
| Azithromycin | 107 | $636 | $6 |
| Levocetirizine Dihydrochloride | 14 | $607 | $43 |
| Levofloxacin | 81 | $606 | $7 |
| Ranitidine | 30 | $537 | $18 |
| Naproxen | 67 | $424 | $6 |
| Clindamycin | 21 | $401 | $19 |
| Calcitriol | 14 | $383 | $27 |
| Ibuprofen | 52 | $328 | $6 |
| Pantoprazole | 15 | $197 | $13 |
| Ondansetron | 14 | $191 | $14 |
| Acetaminophen-Codeine | 11 | $119 | $11 |
| Mupirocin | 14 | $107 | $8 |
| Amoxicillin | 14 | $97 | $7 |
| Ibu | 14 | $75 | $5 |
| Prednisone | 12 | $65 | $5 |
2018: 36 drugs
| Dexilant | 85 | $40,526 | $477 |
| Ciprodex | 172 | $37,662 | $219 |
| Montelukast | 1,390 | $35,160 | $25 |
| Fluticasone Propionate | 992 | $17,669 | $18 |
| Neomycin-Polymyxin-Hydrocort | 229 | $13,830 | $60 |
| Ofloxacin | 111 | $12,195 | $110 |
| Omeprazole | 412 | $10,960 | $27 |
| Azelastine | 179 | $9,891 | $55 |
| Fluocinolone Acetonide Oil | 48 | $7,150 | $149 |
| Triamcinolone Acetonide | 41 | $6,492 | $158 |
| Esomeprazole Magnesium | 21 | $5,725 | $273 |
| Pazeo | 18 | $3,581 | $199 |
| Qnasl | 17 | $3,457 | $203 |
| Amoxicillin-Clavulanate Potass | 166 | $2,943 | $18 |
| Mometasone Furoate | 41 | $2,760 | $67 |
| Meclizine | 193 | $2,654 | $14 |
| Neomycin-Polymyxin-Hc | 28 | $1,932 | $69 |
| Methylprednisolone | 106 | $1,651 | $16 |
| Clotrimazole-Betamethasone | 13 | $1,224 | $94 |
| Ciprofloxacin | 41 | $1,177 | $29 |
| Levofloxacin | 81 | $952 | $12 |
| Naproxen | 114 | $898 | $8 |
| Cephalexin | 68 | $782 | $12 |
| Acetaminophen-Codeine | 77 | $615 | $8 |
| Azithromycin | 65 | $556 | $9 |
| Calcitriol | 14 | $522 | $37 |
| Nystatin | 12 | $521 | $43 |
| Ranitidine | 36 | $500 | $14 |
| Carbamazepine | 11 | $450 | $41 |
| Clindamycin | 11 | $267 | $24 |
| Mupirocin | 19 | $203 | $11 |
| Ondansetron | 15 | $157 | $10 |
| Prednisone | 20 | $128 | $6 |
| Amoxicillin | 13 | $126 | $10 |
| Lorazepam | 22 | $74 | $3 |
| Diazepam | 11 | $23 | $2 |
2017: 38 drugs
| Dexilant | 108 | $42,832 | $397 |
| Montelukast | 1,327 | $27,390 | $21 |
| Ciprodex | 86 | $17,538 | $204 |
| Fluticasone Propionate | 1,126 | $14,015 | $12 |
| Fluocinolone Acetonide Oil | 78 | $12,194 | $156 |
| Ofloxacin | 113 | $11,660 | $103 |
| Neomycin-Polymyxin-Hydrocort | 183 | $9,569 | $52 |
| Omeprazole | 469 | $8,137 | $17 |
| Esomeprazole Magnesium | 22 | $7,224 | $328 |
| Triamcinolone Acetonide | 72 | $7,008 | $97 |
| Nasonex | 21 | $6,754 | $322 |
| Azelastine | 159 | $5,336 | $34 |
| Mometasone Furoate | 52 | $4,291 | $83 |
| Pazeo | 13 | $3,736 | $287 |
| Meclizine | 204 | $2,619 | $13 |
| Qnasl | 13 | $2,495 | $192 |
| Amoxicillin-Clavulanate Potass | 147 | $2,434 | $17 |
| Dymista | 13 | $2,306 | $177 |
| Neomycin-Polymyxin-Hc | 36 | $2,097 | $58 |
| Clotrimazole-Betamethasone | 14 | $1,415 | $101 |
| Methylprednisolone | 97 | $1,246 | $13 |
| Pilocarpine | 14 | $1,078 | $77 |
| Hydrocortisone-Acetic Acid | 12 | $1,024 | $85 |
| Levofloxacin | 99 | $851 | $9 |
| Carbamazepine | 31 | $740 | $24 |
| Cephalexin | 75 | $683 | $9 |
| Acetaminophen-Codeine | 98 | $670 | $7 |
| Nystatin | 16 | $503 | $31 |
| Ciprofloxacin | 27 | $439 | $16 |
| Azithromycin | 62 | $397 | $6 |
| Calcitriol | 13 | $386 | $30 |
| Naproxen | 54 | $313 | $6 |
| Doxazosin Mesylate | 12 | $256 | $21 |
| Lidocaine Hcl Viscous | 14 | $226 | $16 |
| Pantoprazole | 18 | $216 | $12 |
| Clindamycin | 12 | $201 | $17 |
| Amoxicillin | 14 | $103 | $7 |
| Lorazepam | 11 | $30 | $3 |
2016: 50 drugs
| Dexilant | 101 | $34,453 | $341 |
| Montelukast | 1,126 | $25,915 | $23 |
| Ciprodex | 108 | $20,869 | $193 |
| Fluticasone Propionate | 977 | $12,472 | $13 |
| Neomycin-Polymyxin-Hydrocort | 203 | $10,969 | $54 |
| Nasonex | 37 | $10,283 | $278 |
| Fluocinolone Acetonide Oil | 57 | $9,775 | $171 |
| Nexium | 13 | $9,287 | $714 |
| Azelastine | 169 | $7,884 | $47 |
| Omeprazole | 437 | $6,680 | $15 |
| Ofloxacin | 104 | $6,383 | $61 |
| Albuterol Sulfate | 15 | $5,965 | $398 |
| Ranexa | 14 | $5,836 | $417 |
| Triamcinolone Acetonide | 35 | $5,600 | $160 |
| Coreg Cr | 13 | $4,327 | $333 |
| Pataday | 18 | $3,884 | $216 |
| Qnasl | 18 | $3,473 | $193 |
| Dymista | 19 | $3,406 | $179 |
| Amoxicillin-Clavulanate Potass | 143 | $2,954 | $21 |
| Meclizine | 189 | $2,874 | $15 |
| Mometasone Furoate | 26 | $2,432 | $94 |
| Pilocarpine | 28 | $2,190 | $78 |
| Ventolin Hfa | 25 | $2,014 | $81 |
| Neomycin-Polymyxin-Hc | 44 | $1,972 | $45 |
| Methylprednisolone | 94 | $1,757 | $19 |
| Clotrimazole-Betamethasone | 17 | $1,622 | $95 |
| Levofloxacin | 107 | $1,507 | $14 |
| Acetaminophen-Codeine | 105 | $858 | $8 |
| Cephalexin | 83 | $718 | $9 |
| Nystatin | 14 | $600 | $43 |
| Ciprofloxacin | 37 | $582 | $16 |
| Repaglinide | 11 | $567 | $52 |
| Levothyroxine | 25 | $506 | $20 |
| Carbamazepine | 24 | $441 | $18 |
| Clindamycin | 19 | $397 | $21 |
| Pantoprazole | 26 | $374 | $14 |
| Naproxen | 65 | $336 | $5 |
| Azithromycin | 35 | $320 | $9 |
| Mupirocin | 27 | $236 | $9 |
| Doxazosin Mesylate | 12 | $231 | $19 |
| Losartan | 11 | $167 | $15 |
| Prednisone | 22 | $166 | $8 |
| Amoxicillin | 16 | $159 | $10 |
| Ranitidine | 17 | $143 | $8 |
| Latanoprost | 13 | $137 | $11 |
| Metformin | 13 | $70 | $5 |
| Lidocaine Hcl Viscous | 11 | $55 | $5 |
| Simvastatin | 12 | $46 | $4 |
| Lorazepam | 11 | $39 | $4 |
| Amlodipine Besylate | 12 | $35 | $3 |
2015: 44 drugs
| Dexilant | 148 | $43,416 | $293 |
| Montelukast | 942 | $22,080 | $23 |
| Nasonex | 84 | $18,841 | $224 |
| Fluticasone Propionate | 1,000 | $15,428 | $15 |
| Ofloxacin | 192 | $13,865 | $72 |
| Ciprodex | 76 | $13,502 | $178 |
| Fluocinolone Acetonide Oil | 62 | $10,403 | $168 |
| Omeprazole | 563 | $9,351 | $17 |
| Pataday | 48 | $8,773 | $183 |
| Nexium | 12 | $7,933 | $661 |
| Azelastine | 130 | $6,987 | $54 |
| Ranexa | 14 | $4,491 | $321 |
| Neomycin-Polymyxin-Hydrocort | 121 | $4,479 | $37 |
| Amoxicillin-Clavulanate Potass | 145 | $3,456 | $24 |
| Clotrimazole-Betamethasone | 27 | $2,886 | $107 |
| Coreg Cr | 12 | $2,570 | $214 |
| Methylprednisolone | 114 | $2,413 | $21 |
| Meclizine | 158 | $2,374 | $15 |
| Pilocarpine | 18 | $1,905 | $106 |
| Nystatin | 22 | $1,049 | $48 |
| Triamcinolone Acetonide | 12 | $1,039 | $87 |
| Cephalexin | 99 | $955 | $10 |
| Levofloxacin | 58 | $754 | $13 |
| Neomycin-Polymyxin-Hc | 21 | $714 | $34 |
| Acetaminophen-Codeine | 87 | $689 | $8 |
| Ciprofloxacin | 52 | $643 | $12 |
| Carbamazepine | 29 | $638 | $22 |
| Ventolin Hfa | 11 | $560 | $51 |
| Pantoprazole | 37 | $388 | $10 |
| Levothyroxine | 15 | $379 | $25 |
| Naproxen | 63 | $353 | $6 |
| Azithromycin | 47 | $347 | $7 |
| Clindamycin | 13 | $261 | $20 |
| Mometasone Furoate | 14 | $212 | $15 |
| Amoxicillin | 21 | $209 | $10 |
| Ranitidine | 25 | $184 | $7 |
| Atorvastatin | 15 | $182 | $12 |
| Mupirocin | 14 | $151 | $11 |
| Latanoprost | 12 | $130 | $11 |
| Allopurinol | 13 | $115 | $9 |
| Metformin | 21 | $111 | $5 |
| Prednisone | 12 | $87 | $7 |
| Lorazepam | 15 | $63 | $4 |
| Diazepam | 12 | $38 | $3 |
2014: 47 drugs
| Dexilant | 130 | $24,647 | $190 |
| Nasonex | 122 | $22,174 | $182 |
| Fluticasone Propionate | 1,051 | $18,580 | $18 |
| Montelukast | 685 | $15,180 | $22 |
| Fluocinolone Acetonide Oil | 92 | $15,144 | $165 |
| Ciprodex | 86 | $13,665 | $159 |
| Omeprazole | 650 | $8,620 | $13 |
| Nexium | 24 | $8,505 | $354 |
| Azelastine | 114 | $6,824 | $60 |
| Pataday | 40 | $5,877 | $147 |
| Ofloxacin | 158 | $4,648 | $29 |
| Pilocarpine | 36 | $2,684 | $75 |
| Repaglinide | 12 | $2,430 | $202 |
| Coreg Cr | 14 | $2,399 | $171 |
| Amox Tr-Potassium Clavulanate | 104 | $2,314 | $22 |
| Neomycin-Polymyxin-Hydrocort | 82 | $1,880 | $23 |
| Meclizine | 168 | $1,785 | $11 |
| Triamcinolone Acetonide | 30 | $1,688 | $56 |
| Methylprednisolone | 66 | $1,490 | $23 |
| Nystatin | 27 | $1,372 | $51 |
| Clotrimazole-Betamethasone | 11 | $1,253 | $114 |
| Cephalexin | 111 | $1,182 | $11 |
| Acetaminophen-Codeine | 124 | $1,000 | $8 |
| Fluocinolone Acetonide | 11 | $968 | $88 |
| Xopenex Hfa | 11 | $590 | $54 |
| Ciprofloxacin | 60 | $567 | $9 |
| Neomycin-Polymyxin-Hc | 22 | $523 | $24 |
| Levofloxacin | 38 | $482 | $13 |
| Azithromycin | 49 | $454 | $9 |
| Carbamazepine | 33 | $402 | $12 |
| Pantoprazole | 38 | $371 | $10 |
| Atorvastatin | 25 | $312 | $12 |
| Naproxen | 58 | $295 | $5 |
| Levocetirizine Dihydrochloride | 12 | $258 | $21 |
| Clindamycin | 11 | $246 | $22 |
| Losartan | 16 | $198 | $12 |
| Ranitidine | 26 | $186 | $7 |
| Metformin | 20 | $158 | $8 |
| Mupirocin | 13 | $146 | $11 |
| Amoxicillin | 12 | $145 | $12 |
| Latanoprost | 14 | $130 | $9 |
| Lorazepam | 18 | $111 | $6 |
| Allopurinol | 14 | $88 | $6 |
| Sulfamethoxazole-Trimethoprim | 11 | $81 | $7 |
| Prednisone | 11 | $79 | $7 |
| Simvastatin | 12 | $59 | $5 |
| Diazepam | 15 | $56 | $4 |
2013: 44 drugs
| Fluticasone Propionate | 1,063 | $26,888 | $25 |
| Dexilant | 145 | $24,212 | $167 |
| Nasonex | 149 | $23,606 | $158 |
| Nexium | 64 | $16,031 | $250 |
| Montelukast | 478 | $15,195 | $32 |
| Ciprodex | 75 | $12,317 | $164 |
| Omeprazole | 606 | $9,013 | $15 |
| Azelastine | 66 | $5,406 | $82 |
| Singulair | 17 | $4,526 | $266 |
| Fluocinolone Acetonide Oil | 69 | $4,501 | $65 |
| Coreg Cr | 21 | $3,732 | $178 |
| Amox Tr-Potassium Clavulanate | 116 | $3,668 | $32 |
| Ofloxacin | 165 | $3,242 | $20 |
| Pataday | 25 | $3,149 | $126 |
| Astepro | 20 | $2,780 | $139 |
| Avelox | 12 | $2,719 | $227 |
| Pilocarpine | 35 | $2,033 | $58 |
| Triamcinolone Acetonide | 19 | $1,835 | $97 |
| Meclizine | 155 | $1,791 | $12 |
| Neomycin-Polymyxin-Hydrocort | 81 | $1,709 | $21 |
| Fluocinolone Acetonide | 15 | $1,652 | $110 |
| Nystatin | 28 | $1,591 | $57 |
| Cephalexin | 126 | $1,540 | $12 |
| Methylprednisolone | 56 | $1,333 | $24 |
| Acetaminophen-Codeine | 119 | $1,086 | $9 |
| Ciprofloxacin | 60 | $934 | $16 |
| Pantoprazole | 56 | $780 | $14 |
| Atorvastatin | 30 | $572 | $19 |
| Azithromycin | 56 | $559 | $10 |
| Levocetirizine Dihydrochloride | 19 | $517 | $27 |
| Levofloxacin | 36 | $483 | $13 |
| Neomycin-Polymyxin-Hc | 19 | $432 | $23 |
| Clopidogrel | 12 | $408 | $34 |
| Clindamycin | 15 | $376 | $25 |
| Naproxen | 60 | $346 | $6 |
| Carbamazepine | 44 | $288 | $7 |
| Metformin | 17 | $280 | $16 |
| Ranitidine | 31 | $219 | $7 |
| Amoxicillin | 18 | $197 | $11 |
| Hydrocodone-Acetaminophen | 18 | $126 | $7 |
| Lorazepam | 25 | $123 | $5 |
| Allopurinol | 23 | $103 | $4 |
| Prednisone | 11 | $62 | $6 |
| Diazepam | 15 | $53 | $4 |
Money from drug and device companies
$406 in 2025
| 2025 | 3 | 14 | None | $406 |
| 2024 | 1 | 1 | None | $21 |
| 2023 | 3 | 4 | None | $83 |
| 2022 | 2 | 2 | None | $50 |
| 2021 | 1 | 1 | None | $20 |
| 2020 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Nucala | $249 | 12 payments
|
| Madrigal Pharmaceuticals | Rezdiffra | $125 | 1 payment
|
| Phathom Pharmaceuticals | Voquezna | $32 | 1 payment
|
See all 14 published payments
| Madrigal Pharmaceuticals | Meals · 2025-11-19 | Rezdiffra | $125 |
| Phathom Pharmaceuticals | Meals · 2025-11-12 | Voquezna | $32 |
| GlaxoSmithKline | Meals · 2025-11-10 | Nucala | $34 |
| GlaxoSmithKline | Meals · 2025-10-09 | Nucala | $21 |
| GlaxoSmithKline | Meals · 2025-10-01 | Nucala | $15 |
| GlaxoSmithKline | Meals · 2025-09-04 | Nucala | $14 |
| GlaxoSmithKline | Meals · 2025-08-29 | Nucala | $5 |
| GlaxoSmithKline | Meals · 2025-08-08 | Nucala | $35 |
| GlaxoSmithKline | Meals · 2025-06-02 | Nucala | $8 |
| GlaxoSmithKline | Meals · 2025-04-26 | Nucala | $34 |
| GlaxoSmithKline | Meals · 2025-03-31 | Nucala | $10 |
| GlaxoSmithKline | Meals · 2025-03-12 | Nucala | $7 |
| GlaxoSmithKline | Meals · 2025-03-07 | Nucala | $34 |
| GlaxoSmithKline | Meals · 2025-01-29 | Nucala | $33 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $21
| Optinose US | Xhance | $21 | 1 payment
|
2023: $83
| GlaxoSmithKline | Nucala | $47 | 2 payments
|
| Inspire Medical Systems | Inspire | $19 | 1 payment
|
| Optinose US | Xhance | $18 | 1 payment
|
2022: $50
| Genzyme | Dupixent | $33 | 1 payment
|
| GlaxoSmithKline | Nucala | $17 | 1 payment
|
2021: $20
| Stryker | Xpress Ent Dilation System | $20 | 1 payment
|
2020: $23
| OptiNose US | Xhance | $23 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1568400885
- Licence
- CA G39256California G39256: Current · expires 2027-05-31
- Trained
- Creighton University School of Medicine, 1974 · 52 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 11480 Brookshire Ave, Suite 303, Downey, CA, 90241
- NPI first listed
- 2006-06-02
- NPI last updated
- 2023-10-11
- NPI record certified
- 2023-10-11
This is when the NPI record was last certified, not a medical board exam.